A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the safety and efficacy of topiramate in the treatment of obese, type 2 diabetic patients on a controlled diet.

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the safety and efficacy of topiramate in the treatment of obese, type 2 diabetic patients on a controlled diet.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Jun 2009

At a glance

  • Drugs Topiramate (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Jun 2009 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 23 Jun 2009 Actual end date (1 May 2002) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top